Iovance Biotherapeutics, Inc.
2019 Q4 - 2025 Q4 (25 filings)
Shares History
History scope: non-option holdings only (PUT/CALL rows excluded).
| All 13F Holders | Filing date | Value ($000s) | % of Holdings | Shares | Reporting period |
|---|---|---|---|---|---|
| 2025 Q4 | 1/27/2026 | 136 | 0.0% | 49,914 | 12/31/2025 |
| 2025 Q3 | 11/14/2025 | 74 | 0.0% | 33,922 | 9/30/2025 |
| 2025 Q2 | 8/7/2025 | 95 | 0.0% | 55,258 | 6/30/2025 |
| 2025 Q1 | 5/7/2025 | 184 | 0.0% | 55,302 | 3/31/2025 |
| 2024 Q4 | 2/7/2025 | 435 | 0.0% | 58,771 | 12/31/2024 |
| 2024 Q3 | 11/14/2024 | 556 | 0.0% | 59,172 | 9/30/2024 |
| 2024 Q2 | 7/29/2024 | 473 | 0.0% | 59,020 | 6/30/2024 |
| 2024 Q1 | 4/25/2024 | 871 | 0.0% | 58,753 | 3/31/2024 |
| 2023 Q4 | 1/30/2024 | 359 | 0.0% | 44,145 | 12/31/2023 |
| 2023 Q3 | 10/25/2023 | 177 | 0.0% | 38,990 | 9/30/2023 |
| 2023 Q2 | 8/7/2023 | 191 | 0.0% | 27,160 | 6/30/2023 |
| 2023 Q1 | 5/8/2023 | 90 | 0.0% | 14,761 | 3/31/2023 |
| 2022 Q4 | 2/1/2023 | 94 | 0.0% | 14,761 | 12/31/2022 |
| 2022 Q3 | 11/9/2022 | 141 | 0.0% | 14,761 | 9/30/2022 |
| 2022 Q2 | 8/9/2022 | 163 | 0.0% | 14,761 | 6/30/2022 |
| 2022 Q1 | 4/21/2022 | 304 | 0.0% | 18,247 | 3/31/2022 |
| 2021 Q4 | 2/1/2022 | 370 | 0.0% | 19,408 | 12/31/2021 |
| 2021 Q3 | 11/15/2021 | 325 | 0.0% | 13,191 | 9/30/2021 |
| 2021 Q2 | 7/30/2021 | 343 | 0.0% | 13,197 | 6/30/2021 |
| 2021 Q1 | 5/3/2021 | 416 | 0.0% | 13,136 | 3/31/2021 |
| 2020 Q4 | 1/28/2021 | 644 | 0.0% | 13,883 | 12/31/2020 |
| 2020 Q3 | 11/6/2020 | 394 | 0.0% | 11,959 | 9/30/2020 |
| 2020 Q2 | 7/28/2020 | 301 | 0.0% | 10,957 | 6/30/2020 |
| 2020 Q1 | 5/6/2020 | 278 | 0.0% | 9,285 | 3/31/2020 |
| 2019 Q4 | 1/21/2020 | 220 | 0.0% | 7,953 | 12/31/2019 |